How Imipenem can Save You Time, Stress, and Money.
MI-CP151 was a period 1b randomised, double-blind, placebo managed, dose-escalation, multicentre analyze To judge several intravenous doses of sifalimumab, in Grownup people with dermatomyositis or polymyositis (NCT00533091). Key demo objectives had been To guage the protection and tolerability of sifalimumab in dermatomyositis or polymyositis suff